← All reportsView on Symbol
CNC

CNC

High conviction

Centene Corp.

Healthcare · NYSE

$32.4B mkt cap

Brief updated Jun 28, 2026

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance

Decifer Research·AI synthesis

Centene catches a risk-off bid, but a negative net margin hides beneath the managed care narrative.

Centene is a managed care operator serving Medicaid, Medicare, and commercial populations — a defensive business profile that becomes a direct beneficiary when investors rotate away from risk assets. The composite conviction score of 68 out of 100 and a unanimous analyst buy consensus suggest institutional confidence in the setup. Revenue growth of 44 percent year over year is genuinely strong. However, a net margin of negative 325 percent is the number that demands explanation — it signals that top-line growth is currently masking deep operational or one-time losses that the bull case is underweighting.

Why now

An active risk-off rotation is adding an estimated 20 points of macro tailwind to Centene's setup, with strong supporting evidence adding another 5 — this is a live catalyst, not a theoretical one. Simultaneously, a potential Federal Reserve rate hike in as little as six weeks, flagged by a JPMorgan executive, could pressure the broader equity market and accelerate defensive rotation into managed care names.

Key risks

The negative 325 percent net margin is the central unresolved risk — if losses stem from structural Medicaid underfunding, a rate-hike environment will not fix them and the DCF intrinsic value of 125 dollars becomes unreliable. A rate hike in six weeks could also tighten Centene's cost of capital and compress multiples across healthcare, even for defensive names. The current price-to-earnings ratio is negative 5 times, meaning the market is already pricing in losses — any miss on the path back to profitability breaks the recovery narrative.

What to watch

The single most important indicator is whether net margin turns positive — watch the next two quarterly earnings reports for evidence that the loss driver is non-recurring rather than structural. Also watch Medicaid redetermination enrollment data from state agencies, as membership attrition in that segment is the most likely explanation for margin collapse and would directly challenge the 44 percent revenue growth sustainability.

51High conviction Conviction
macro
25/25
analyst
5/38
momentum
20/20
forward catalyst
4/15
valuation
14/23
highs
12/12
news catalyst
0/12
options flow
0/12
peer network
8/8
counter thesis
0/3
Key financials
Revenue growth (YoY)44.0%
Gross margin1493.0%
Operating margin-368.0%
Net margin-325.0%
P/E ratio-5.0x
Return on equity-2872.0%
FCF yield1956.0%
Debt / equity0.8x
EV / sales0.1x
Valuation
Analyst consensusBUY
DCF fair value$125
Next EPS estimate$-0.20
Macro context
Risk-off rotation underway

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid US Attacks on Iran

The US has launched attacks on Iran, leading to increased geopolitical tensions and a rise in risk-off sentiment, with exchange-traded funds and equity futures higher pre-bell on Thursday as investors seek safe-haven assets.

Jun 15, 2026

Circle Your Calendars for July 29. JPMorgan Executive Says Fed Chair Kevin Warsh Could Raise Rates in As Little as Six Weeks.

JPMorgan executive suggests Fed Chair Kevin Warsh may raise interest rates as early as six weeks from July 29, indicating a potential shift in monetary policy. This could impact market expectations and asset prices.

Jun 22, 2026

Gold Extends Losses as Fed Rate-Hike Outlook Supports Dollar

The Federal Reserve's outlook on interest rate hikes has strengthened, supporting the US dollar and leading to extended losses in gold prices. This development may impact investor risk appetite and currency markets.

Jun 22, 2026

Chart of the Day 6-19-26- In Warsh's Wake, Hike Odds Spike

The odds of a interest rate hike have increased following comments from a key central bank official, indicating a potential shift in monetary policy. This change in guidance could impact market expectations and asset prices.

Jun 22, 2026

Analyst intelligence
27 Buy15 Hold1 Sell
Earnings intelligence

Earnings surprises

+51.1%

2026-04

+2.5%

2026-02

+445.4%

2025-10

-243.4%

2025-07

+15.1%

2025-04

Recent updates
other macro4d ago

TSMC stock drops 4.1% amid a $2 trillion AI rout, indicating a potential shift in investor sentiment towards AI-related stocks and the broader tech sector. This event may have implications for the tech industry and the global economy.

geopolitical escalation4d ago

The US equity indexes are sliding ahead of Fed Governor Warsh's press briefing and big-tech results, as President Trump vows to hit Iran hard, escalating geopolitical tensions. This escalation could lead to increased market volatility and risk aversion.

central bank rate decision4d ago

The equities market is experiencing intraday losses ahead of the highly anticipated Federal Reserve decision, which could significantly impact market direction and investor sentiment. The decision, coupled with major tech earnings reports, is poised to influence the overall economic outlook.

geopolitical escalationJul 16, 2026

Escalating tensions between the U.S. and Iran are weighing on broader market sentiment, causing investors to reduce exposure to risk assets, including crypto-linked companies. This geopolitical uncertainty is leading to a decline in Bitcoin prices and affecting market sentiment.

geopolitical escalationJul 16, 2026

The US-Iran war fear has reemerged, causing the S&P 500, Nasdaq, and Dow to end lower, as investors become increasingly risk-averse due to the potential for conflict escalation.

Generated Sun, 28 Jun 2026 06:18:22 GMT by Decifer intelligence engine. For informational purposes only — not investment advice. Decifer Intelligence Hub.